4.8 Article

Engineering multifunctional metal/protein hybrid nanomaterials as tools for therapeutic intervention and high-sensitivity detection

Journal

CHEMICAL SCIENCE
Volume 12, Issue 7, Pages 2480-2487

Publisher

ROYAL SOC CHEMISTRY
DOI: 10.1039/d0sc05215a

Keywords

-

Funding

  1. European Research Council [ERC-PoC-841063-NIMM, ERC-CoG-648071-ProNANO]
  2. Agencia Estatal de Investigacion, Spain [PID2019-111649RB-I00, RTI2018-095214-B-I00, BIO2016-77367-C2-1-R, BIO2015-72124-EXP]
  3. Basque Government [Elkartek KK-2017/00008, RIS3-2019222005]
  4. Gipuzkoa Foru Aldundia (Gipuzkoa Fellows program) [2019-FELL-000018-01/62/2019]
  5. Spanish Ministry of Science and Innovation [BES-2017-079646]
  6. Maria de Maeztu Units of Excellence Program from the Spanish State Research Agency [MDM-2017-0720]
  7. IDIVAL [InnVal 17/22]

Ask authors/readers for more resources

This work demonstrates a novel approach to design custom protein hybrid nanomaterials by combining a therapeutic protein module with a nanomaterial-stabilizing module. The designed multifunctional system for therapeutic intervention and monitoring of myocardial fibrosis successfully reduced fibrosis and heart hypertrophy in an animal model. The study highlights the potential of combining protein engineering and nanomaterial engineering for designing custom nanomaterials as theranostic tools in medicine.
Protein-based hybrid nanomaterials have recently emerged as promising platforms to fabricate tailored multifunctional biologics for biotechnological and biomedical applications. This work shows a simple, modular, and versatile strategy to design custom protein hybrid nanomaterials. This approach combines for the first time the engineering of a therapeutic protein module with the engineering of a nanomaterial-stabilizing module within the same molecule, resulting in a multifunctional hybrid nanocomposite unachievable through conventional material synthesis methodologies. As the first proof of concept, a multifunctional system was designed ad hoc for the therapeutic intervention and monitoring of myocardial fibrosis. This hybrid nanomaterial combines a designed Hsp90 inhibitory domain and a metal nanocluster stabilizing module resulting in a biologic drug labelled with a metal nanocluster. The engineered nanomaterial actively reduced myocardial fibrosis and heart hypertrophy in an animal model of cardiac remodeling. In addition to the therapeutic effect, the metal nanocluster allowed for in vitro, ex vivo, and in vivo detection and imaging of the fibrotic disease under study. This study evidences the potential of combining protein engineering and protein-directed nanomaterial engineering approaches to design custom nanomaterials as theranostic tools, opening up unexplored routes to date for the next generation of advanced nanomaterials in medicine.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available